People News: Abbott Labs and Lux Biosciences

Share this article:

Abbott Laboratories executive vice president of pharmaceuticals Olivier Bohuon is leaving the company to become CEO at Pierre Fabre Group, a French pharmaceutical company, beginning September 1. Richard Gonzalez, a former president and COO at Abbott, will lead Abbott's pharmaceutical division on an interim basis, according to an Associated Press report. Abbott's pharmaceutical division is responsible for the lion's share of the company's total revenue, due mostly to Humira, a blockbuster injection indicated for rheumatoid arthritis, Crohn's disease and other inflammatory conditions. The pharmaceuticals division pulled in $4.1 billion in sales for the first quarter of 2010, according to the AP.

Lux Biosciences hired Dean Mitchell as president and CEO. Mitchell had been president and CEO of Alpharma before that company was acquired by King in 2008.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in People Moves

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in People Moves

Monday Moves: October 20

Promotions and hires for agencies and manufacturers

Monday Moves: September 29

Promotions and hires for agencies and manufacturers

Monday Moves—July 21, 2014

Hires and promotions for Manufacturers, Agencies and Media